Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Ethics Forum: Understanding the Challenges in Rheumatology Today

C. Ronald MacKenzie, MD, Elizabeth, Kitsis, MD, MBE, and Michele Meltzer, MD, MBE  |  Issue: July 2010  |  July 1, 2010

You can scarcely open a newspaper or medical journal today without confronting a discussion pertaining to an issue involving medical ethics. Yet, despite the intense scrutiny of this subject from both inside and outside the medical profession, a recent paper published in Arthritis Care and Research (AC&R) pointed to a dearth of ethical discourse in the rheumatology literature.1,2 In order to explore the range of ethical challenges facing our professional community and discuss their implications, the ACR Committee on Ethics and Conflict of Interest is collaborating with The Rheumatologist to create a new feature called the “Ethics Forum.” This new quarterly department will foster dialog among rheumatologists and rheumatology health professionals concerning real life ethical issues that they may encounter in medical practice or research.

In each edition of the “Ethics Forum,” a member of the Committee on Ethics and Conflict of Interest will analyze brief clinical vignettes that illustrate ethical dilemmas arising from everyday practice. This discussion will concern the ethical principles involved and provide guidance for resolving the dilemma. The goal of these discussions is to be practical rather than theoretical. If you have an ethics question that you’ve encountered in practice, or if you have questions or comments about an “Ethics Forum” case, write us at [email protected]. We may publish your letter or question in a future “Ethics Forum.” We hope that you enjoy this first ethics case study—and that you write in with your own experiences or to ask a question for an issue that has challenged you.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Case

You have been contacted by a pharmacy to renew methotrexate for a patient with longstanding rheumatoid arthritis. After realizing that she has not had lab monitoring or an office follow-up for a long time, the patient was contacted. The patient says that she is doing well on the methotrexate but has lost her health insurance coverage so she cannot afford office visits or laboratory studies. Despite a social work referral, the patient has been unable to get the lab test, or at least has not obtained a way of getting the lab testing performed. She says she knows and accepts the risks of taking methotrexate without monitoring and wants you to renew her medications until she obtains health insurance, at which time she will see you and have the testing done.

Ethical problem: What should a physician do when faced with an ethical problem that threatens to disrupt the planning or provision of care for a patient?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:EthicsProfessional Topics Tagged with:EthicsHealth InsuranceMethotrexateRheumatoid arthritisrheumatology

Related Articles

    Ethics Forum: To Test or Not to Test?

    October 13, 2021

    “Maria” is a 54-year-old woman with seropositive rheumatoid arthritis, as well as hypertension and hyperlipidemia. She is a new patient in your clinic following a move across the country to live with her children on a farm in a rural area of the Midwest. At her first visit, three months ago, you and Maria agreed—through…

    Updated ACP Ethics Manual Provides 6-Step Approach to Dilemmas

    January 15, 2019

    NEW YORK (Reuters Health)—The 2019 edition of the American College of Physicians (ACP) ethics manual provides a six-step approach to resolving ethical dilemmas and adds or expands sections that address emerging issues in 21st century medicine.1 “The Manual provides succinct guidance on issues that affect the patient-physician relationship, and also issues that have to do…

    AMA Updates Code of Medical Ethics

    January 17, 2017

    Eight years ago, the American Medical Association’s (AMA) Council on Ethical and Judicial Affairs embarked on a comprehensive review of the AMA Code of Medical Ethics. What emerged after years of hard effort, intensive feedback and thoughtful revisions was a modernized version of the guide, which the AMA House of Delegates voted to adopt in…

    Ethics Forum: Vaccine Mandates

    January 10, 2022

    With the ongoing COVID‑19 pandemic, several tools and strategies have been developed and implemented to reduce the spread of disease. These include social distancing, adequate ventilation, masks, monoclonal antibody treatment and vaccination.1 As of December 2021, 60% of all Americans have been fully vaccinated, and 8 in 10 adults in the U.S. have received at…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences